These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 26524629)

  • 21. Inhibition of HIV derived lentiviral production by TAR RNA binding domain of TAT protein.
    Mi MY; Zhang J; He Y
    Retrovirology; 2005 Nov; 2():71. PubMed ID: 16293193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
    Smith CA; Crotty S; Harada Y; Frankel AD
    Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
    Chen S; Chen R; He M; Pang R; Tan Z; Yang M
    Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
    Huq I; Rana TM
    Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological evaluation of substituted guanidine indole derivatives as potential inhibitors of HIV-1 Tat-TAR interaction.
    Wang J; Wang Y; Li Z; Zhan P; Bai R; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Med Chem; 2014; 10(7):738-46. PubMed ID: 24605773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional significance of the dinucleotide bulge in stem-loop1 and stem-loop2 of HIV-2 TAR RNA.
    Rhim H; Rice AP
    Virology; 1994 Jul; 202(1):202-11. PubMed ID: 8009832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antiviral activity of ethidium-arginine conjugates directed against the TAR RNA of HIV-1.
    Peytou V; Condom R; Patino N; Guedj R; Aubertin AM; Gelus N; Bailly C; Terreux R; Cabrol-Bass D
    J Med Chem; 1999 Oct; 42(20):4042-53. PubMed ID: 10514274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA.
    Zhao H; Li J; Xi F; Jiang L
    FEBS Lett; 2004 Apr; 563(1-3):241-5. PubMed ID: 15063756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
    Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
    Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
    Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and bioactivities of TAR RNA targeting beta-carboline derivatives based on Tat-TAR interaction.
    Yu X; Lin W; Pang R; Yang M
    Eur J Med Chem; 2005 Sep; 40(9):831-9. PubMed ID: 15925430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements.
    Athanassiou Z; Dias RL; Moehle K; Dobson N; Varani G; Robinson JA
    J Am Chem Soc; 2004 Jun; 126(22):6906-13. PubMed ID: 15174860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site-specific cross-linking of amino acids in the basic region of human immunodeficiency virus type 1 Tat peptide to chemically modified TAR RNA duplexes.
    Farrow MA; Aboul-ela F; Owen D; Karpeisky A; Beigelman L; Gait MJ
    Biochemistry; 1998 Mar; 37(9):3096-108. PubMed ID: 9485463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction.
    Gatto B; Tabarrini O; Massari S; Giaretta G; Sabatini S; Del Vecchio C; Parolin C; Fravolini A; Palumbo M; Cecchetti V
    ChemMedChem; 2009 Jun; 4(6):935-8. PubMed ID: 19283692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA.
    Long KS; Crothers DM
    Biochemistry; 1999 Aug; 38(31):10059-69. PubMed ID: 10433713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of conformational heterogeneity in ligand recognition by viral RNA molecules.
    Levintov L; Vashisth H
    Phys Chem Chem Phys; 2021 May; 23(19):11211-11223. PubMed ID: 34010381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA's Dynamic Conformational Selection and Entropic Allosteric Mechanism in Controlling Cascade Protein Binding Events.
    Chakraborty A; Samant D; Sarkar R; Sangeet S; Prusty S; Roy S
    J Phys Chem Lett; 2024 Jun; 15(23):6115-6125. PubMed ID: 38830201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of protein side chains with RNA defined with REDOR solid state NMR.
    Huang W; Varani G; Drobny GP
    J Biomol NMR; 2011 Nov; 51(3):347-56. PubMed ID: 21947838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A small-molecule probe induces a conformation in HIV TAR RNA capable of binding drug-like fragments.
    Davidson A; Begley DW; Lau C; Varani G
    J Mol Biol; 2011 Jul; 410(5):984-96. PubMed ID: 21763501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electron paramagnetic resonance dynamic signatures of TAR RNA-small molecule complexes provide insight into RNA structure and recognition.
    Edwards TE; Sigurdsson ST
    Biochemistry; 2002 Dec; 41(50):14843-7. PubMed ID: 12475232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.